| Revenue | 12,275.78a | 11,538a |
| Cost of sales | -8,126.52a | -7,443.18a |
| Gross profit | 4,149.26a | 4,094.82a |
| Other income and gains | 884.52a | 374.01a |
| Other expenses | -67.76a | -37.9a |
| Selling and distribution expenses | -258.43a | -252.78a |
| Administrative expenses | -1,663.6a | -1,671.88a |
| Research and development costs | -469.26a | -448.28a |
| Impairment losses on financial and contract assets, net of reversal | -42.95a | -35.83a |
| Impairment losses of goodwill | -73.54a | 0a |
| Finance costs | -243.72a | -182.19a |
| Share of losses of associates | -123.26a | -2.08a |
| Profit before tax | 2,091.26a | 1,837.89a |
| Income tax expense | -377.1a | -256.11a |
| Profit for the year | 1,714.16a | 1,581.78a |
| Attributable to | — | — |
| Owners of the parent | 1,793.35a | 1,601.1a |
| Non-controlling interests | -79.19a | -19.32a |